BENZIMIDAZOLPROLINDERIVATE

Patent europeic · EP2855453 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2855453
Numer da la dumonda
EP13744805
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
03-06-2013
Publitgà
08-04-2015
Concedì
07-12-2016
La protecziun finescha il pli tard
02-06-2033
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07D 403/14 (2006.01)
C07D 401/14 (2006.01)
C07D 403/04 (2006.01)
C07D 417/14 (2006.01)
Prioritad
EP 12170748 04.06.2012
EP 13158520 11.03.2013
Dumonda PCT
PCT/IB2013/054567 03.06.2013
Publicaziun PCT
WO2013/182972 12.12.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Daridorexantum

C02855453/01 · Medicament · Concedì · Protecziun dals 03-06-2033 fin ils 30-11-2037

Admissiun 68481 (Swissmedic, 01-12-2022)

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2026

    Pegn inscrit

    Pledgee
    BioPharma Credit PLC, 19th Floor 51 Lime Street, London, United Kingdom, EC3M 7DQ, United Kingdom

    Published in Swissreg on 01.07.2026

  3. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. 25-11-2024

    Licenza inscritta

    License holder
    Nxera Pharma Japan Co., Ltd., 9-7-2 Akasaka Minato-ku, 107-0052 Tokyo, Japan

    Published in Swissreg on 25.11.2024

  5. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  6. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  7. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  8. 14-09-2017

    Transferì

    Owner
    Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil → Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123 Allschwil

    Published in Swissreg on 14.09.2017

1 endataziun pli veglia
  1. 07-12-2016

    Concedì

    Published in Swissreg on 07.12.2016

Partidas

Possessur

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91, 4123 Allschwil

Inventur

BOSS, Christoph

4123 Allschwil

BROTSCHI, Christine

4123 Allschwil

GUDE, Markus

4123 Allschwil

HEIDMANN, Bibia

4123 Allschwil

SIFFERLEN, Thierry

4123 Allschwil

WILLIAMS, Jodi T.

4123 Allschwil

Licenziat

Nxera Pharma Japan Co., Ltd.

9-7-2 Akasaka Minato-ku, 107-0052 Tokyo, JP

Creditur da pegn

BioPharma Credit PLC

19th Floor 51 Lime Street, London, United Kingdom, EC3M 7DQ, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.